Delivery Order SPE2DB20D3304-SPE2DB24FW4U9

Award Date 12/25/23
Potential Completion Date 12/26/23
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a potential value of $2,770.74 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) the company...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals. The $2,770.74 award has a performance period through February 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. The $4,455.88 order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a potential value of $3,705.92 and a performance period through March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The order has a potential value of $4,416.36 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc., which does business as Amerisourcebergen. This delivery order is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The $6,558.30 delivery order has a completion date of January 23, 2024 and was awarded on January 22, 2024. The delivery order is part of AmerisourceBergen Drug Corp's existing indefinite delivery contract to supply pharmaceuticals and medical supplies to DLA Troop...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order to provide the medication HUMIRA(CF) PEN 40 MG/0.4 MLS. The $7,197.93 contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA PEN 40 MG/0.8 MLS. The $3,523.38 order has a completion date of December 28, 2023 and was awarded on December 27, 2023. Amerisourcebergen Drug Corp, a for-profit organization, has an extensive history of supplying pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical under...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,136.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA PEN 40 MG/0.8 MLS. The order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense, through various contracts. This...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,083.84 order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW4U9
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The $7,106.98 order, which has a completion date of December 26, 2023, is part of DLA's broader efforts to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime contractor, has extensive experience delivering a range of pharmaceutical and medical products to the Department of Defense under multiple DLA contracts. This delivery order did not have a set-aside designation.

Generated 3/31/24, 12:01 AM